Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.670
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
2.570
-0.100 (-3.75%)
Pre-market: Apr 29, 2026, 8:14 AM EDT
Spero Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 40.27 | 52.89 | 76.33 | 109.11 | 112.58 | Upgrade
|
| Short-Term Investments | - | - | - | - | 33.82 | Upgrade
|
| Cash & Short-Term Investments | 40.27 | 52.89 | 76.33 | 109.11 | 146.4 | Upgrade
|
| Cash Growth | -23.87% | -30.71% | -30.04% | -25.47% | 15.36% | Upgrade
|
| Accounts Receivable | 25.36 | 49.39 | 49.15 | - | - | Upgrade
|
| Other Receivables | 0.03 | 3.09 | 1.55 | 1.08 | 2.64 | Upgrade
|
| Receivables | 25.39 | 52.48 | 50.7 | 1.08 | 2.64 | Upgrade
|
| Prepaid Expenses | 1.63 | 1.91 | 4.18 | 3.38 | 8.83 | Upgrade
|
| Total Current Assets | 67.29 | 107.28 | 131.21 | 113.57 | 157.87 | Upgrade
|
| Property, Plant & Equipment | 1.48 | 3.11 | 4.16 | 5.49 | 7.56 | Upgrade
|
| Long-Term Accounts Receivable | - | - | 46.59 | - | - | Upgrade
|
| Other Long-Term Assets | 0.15 | 0.15 | 0.44 | 5.74 | 5.64 | Upgrade
|
| Total Assets | 68.92 | 110.54 | 182.39 | 124.8 | 171.07 | Upgrade
|
| Accounts Payable | 0.69 | 7.31 | 1.38 | 0.62 | 1.1 | Upgrade
|
| Accrued Expenses | 5.58 | 17.27 | 6.56 | 8.53 | 14.35 | Upgrade
|
| Current Portion of Leases | 1.96 | 1.75 | 1.72 | 1.69 | 1.36 | Upgrade
|
| Current Income Taxes Payable | 0.38 | 0.17 | 0.39 | - | - | Upgrade
|
| Current Unearned Revenue | 0.26 | 22.12 | 27.11 | 10.37 | 1.86 | Upgrade
|
| Other Current Liabilities | - | 0.46 | - | 0.45 | - | Upgrade
|
| Total Current Liabilities | 8.87 | 49.07 | 37.15 | 21.65 | 18.67 | Upgrade
|
| Long-Term Debt | - | - | - | - | 48.41 | Upgrade
|
| Long-Term Leases | 0.94 | 2.55 | 3.83 | 4.96 | 5.97 | Upgrade
|
| Long-Term Unearned Revenue | - | 12.8 | 34.43 | 22.17 | 8.79 | Upgrade
|
| Other Long-Term Liabilities | 0.09 | - | 0.09 | 0.1 | 0.94 | Upgrade
|
| Total Liabilities | 9.9 | 64.42 | 75.5 | 48.87 | 82.78 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.05 | 0.05 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 510.03 | 505.71 | 497.91 | 489.76 | 455.72 | Upgrade
|
| Retained Earnings | -451.07 | -459.64 | -391.07 | -413.88 | -367.46 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | -0 | Upgrade
|
| Total Common Equity | 59.02 | 46.12 | 106.89 | 75.93 | 88.29 | Upgrade
|
| Shareholders' Equity | 59.02 | 46.12 | 106.89 | 75.93 | 88.29 | Upgrade
|
| Total Liabilities & Equity | 68.92 | 110.54 | 182.39 | 124.8 | 171.07 | Upgrade
|
| Total Debt | 2.9 | 4.3 | 5.54 | 6.65 | 55.75 | Upgrade
|
| Net Cash (Debt) | 37.37 | 48.59 | 70.79 | 102.46 | 90.65 | Upgrade
|
| Net Cash Growth | -23.09% | -31.36% | -30.91% | 13.02% | -23.86% | Upgrade
|
| Net Cash Per Share | 0.63 | 0.90 | 1.34 | 2.73 | 2.93 | Upgrade
|
| Filing Date Shares Outstanding | 57.89 | 55.9 | 53.87 | 52.57 | 32.76 | Upgrade
|
| Total Common Shares Outstanding | 56.41 | 54.59 | 53 | 52.46 | 32.39 | Upgrade
|
| Working Capital | 58.42 | 58.2 | 94.06 | 91.92 | 139.2 | Upgrade
|
| Book Value Per Share | 1.05 | 0.84 | 2.02 | 1.45 | 2.73 | Upgrade
|
| Tangible Book Value | 59.02 | 46.12 | 106.89 | 75.93 | 88.29 | Upgrade
|
| Tangible Book Value Per Share | 1.05 | 0.84 | 2.02 | 1.45 | 2.73 | Upgrade
|
| Machinery | - | - | 1.55 | 1.55 | 1.76 | Upgrade
|
| Leasehold Improvements | - | - | 1.64 | 1.64 | 1.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.